Supportive Care Interventions in Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis

There is no comprehensive synthesis of supportive care interventions for patients with hematologic malignancies receiving transplantation and cellular therapies (TCTs). This systematic review and meta-analysis aimed to characterize randomized controlled trials (RCTs) of TCT supportive care interventions and examine effects on patient-reported outcomes (PROs). We systematically searched MEDLINE, Embase, CINAHL, PsycInfo, Web of Science, and CENTRAL databases. We used the Cochrane Risk of Bias 2.0 protocol, grouped findings by intervention and PRO types, and synthesized results narratively. We conducted exploratory random-effects meta-analyses to estimate pooled intervention effects on anxiety, depression, and quality of life (QOL). Fifty-three RCTs published from 1992 to 2025 met criteria. All RCTs included hematopoietic stem cell transplantation (HSCT) recipients; none were tested in patients receiving cellular therapies. Included studies reported a range of sample sizes (11-711), participant demographics (mean age 33-63 years; 22-64% female), and PROs. There were nine intervention categories: cognitive behavioral (n=5), exercise only (n=17), expressive helping (n=2), mind-body/stress management (n=7), multimodal (exercise plus another modality; n=6), music/art (n=12), palliative care (n=2), positive psychology (n=1), and self-management/self-efficacy (n=5). Interventions were mostly feasible and acceptable, with promising improvements in psychological distress, QOL, and physical outcomes. Meta-analysis showed non-significant trends toward exercise interventions improving QOL (SMD=0.09; 95% CI: -0.07 to 0.25) and music/art interventions reducing acute depressive symptoms (SMD=-0.26; 95% CI: -0.52 to 0.00). Among patients undergoing HSCT for hematologic malignancies, supportive care interventions show feasibility, acceptability, and promise for improving PROs. However, larger, rigorously designed trials using standardized PRO measures are needed to establish efficacy.

Authors

Institutions

Publication Details

Journal
Blood Advances
Published
2026-04-02
DOI
https://doi.org/10.1182/bloodadvances.2026019724
Primary Topic
Cancer survivorship and care
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supportive Care Interventions in Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis

Lydia Brown, Fernando Díaz González-Colmenero, Natalie Saadeh, Lauren Waldman et al.
Blood Advances
Cancer survivorship and care
article

Supportive Care Interventions in Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis

Lydia Brown, Fernando Díaz González-Colmenero, Natalie Saadeh, Lauren Waldman, Christopher M. Celano, Hermioni L. Amonoo, Michelle Guo, Annabella C. Boardman, Emma D. Wolfe, A. Cronin, Emma P Keane, Daniel A. Schaefer, Isabella S. Larizza, Fabian N. Adri, Andres Ramirez-Gamero, M. Tim Song, Josephine A. Monahan, Jowan Watson, Michael A. Stoto, Stephanie J. Lee, Lisa M Gudenkauf
article en

Abstract

There is no comprehensive synthesis of supportive care interventions for patients with hematologic malignancies receiving transplantation and cellular therapies (TCTs). This systematic review and meta-analysis aimed to characterize randomized controlled trials (RCTs) of TCT supportive care interventions and examine effects on patient-reported outcomes (PROs). We systematically searched MEDLINE, Embase, CINAHL, PsycInfo, Web of Science, and CENTRAL databases. We used the Cochrane Risk of Bias 2.0 protocol, grouped findings by intervention and PRO types, and synthesized results narratively. We conducted exploratory random-effects meta-analyses to estimate pooled intervention effects on anxiety, depression, and quality of life (QOL). Fifty-three RCTs published from 1992 to 2025 met criteria. All RCTs included hematopoietic stem cell transplantation (HSCT) recipients; none were tested in patients receiving cellular therapies. Included studies reported a range of sample sizes (11-711), participant demographics (mean age 33-63 years; 22-64% female), and PROs. There were nine intervention categories: cognitive behavioral (n=5), exercise only (n=17), expressive helping (n=2), mind-body/stress management (n=7), multimodal (exercise plus another modality; n=6), music/art (n=12), palliative care (n=2), positive psychology (n=1), and self-management/self-efficacy (n=5). Interventions were mostly feasible and acceptable, with promising improvements in psychological distress, QOL, and physical outcomes. Meta-analysis showed non-significant trends toward exercise interventions improving QOL (SMD=0.09; 95% CI: -0.07 to 0.25) and music/art interventions reducing acute depressive symptoms (SMD=-0.26; 95% CI: -0.52 to 0.00). Among patients undergoing HSCT for hematologic malignancies, supportive care interventions show feasibility, acceptability, and promise for improving PROs. However, larger, rigorously designed trials using standardized PRO measures are needed to establish efficacy.

Blood Advances
Brigham and Women's Hospital (US), Roger Williams Medical Center (US), Harvard University (US), The University of Melbourne (AU), Providence College (US), University of Washington (US), Boston Public Library (US), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), Dana-Farber Brigham Cancer Center (US), Mass General Brigham (US)
Good health and well-being
Openalex Percentile: Top 29%
Cancer survivorship and care
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.